Description Transforming Discovery and Translational Fibrosis Research into Disease Modifying IPF Therapeutics. Location Boston, Massachusetts, United States Event Type Conference Industry Health Care, Pharmaceutical Regions Greater Boston Area, East Coast, New England Event Organizers Hanson Wade Start Date Aug 21, 2017 End Date Aug 23, 2017 Venue Name Sheraton Boston Hotel Event URL go.evvnt.com/129487-0 Registration URL Click here to register
The inaugural Idiopathic Pulmonary Fibrosis (IPF) Summit is the only event to focus solely on IPF.
This unique meeting is your opportunity to join the leading minds across biopharma and academia to reduce the expansive translational gap that exists in current IPF drug development.
Across 3 jam-packed days the brightest minds from the likes of
Boehringer Ingelheim, Promedior, Fibrogen and many more will be sharing their insight and lessons learned to collectively enable the community to:
- Effectively translate into the clinic by better recapitulating IPF through robust in vitro and vivo models
- Define more meaningful preclinical endpoints to aid identification of novel targets and development of more effective IPF therapeutics
- Validate non-invasive biomarker and diagnostic techniques for back translation and ultimately achieve greater clinical benefit
URL:
Brochure: https://go.evvnt.com/129487-1
Speakers: Clifford D. Wright, Glenn Rosen, Masha Poyurovsky, Seth Porter, Joan Nichols, Lynne Murray, A. Bruce Montgomery, Phillip Monk, Fernando Martinez, Kenneth Lipson, Joseph Jacob, Rick Jack, Cory M. Hogaboam, Gerald Horan, Joe Arron, James A. Cardelli, Sam Cobb, Gregory Cosgrove, Jeremy Duffield, Jonathan Goldin
